Maravai Lifesciences Holdings Inc (MRVI) is a Healthcare · Biotechnology company listed on NASDAQ. Price $6.94 (-4.54%), Market cap $1.53B, 52-week low–high $2.01 ~ $4.85.
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS. The TRILINK segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also
Financial statements, price targets, institutional (13F) holdings and related news for Maravai Lifesciences Holdings Inc are updated in real time on BlackAll Trade.
Maravai Lifesciences Holdings Inc trades at $6.94 (-4.54%). Real-time quotes and charts are available on BlackAll Trade.
Maravai Lifesciences Holdings Inc has a market cap of about $1.53B.
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North